Impact of treatment regimen with moroctocog alfa (AF-CC) on bleeding rates in paediatric patients with severe haemophilia A

Haemophilia. 2020 Sep;26(5):e232-e235. doi: 10.1111/hae.14047. Epub 2020 Jun 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Factor VIII / therapeutic use*
  • Hemophilia A / drug therapy*
  • Humans
  • Infant
  • Infant, Newborn

Substances

  • recombinant factor VIII SQ
  • Factor VIII

Grants and funding